Related Experiment Videos
Staphylococcal central nervous system infections treated with cloxacillin
The Journal of Antimicrobial Chemotherapy
|December 1, 1983
Summary
Cloxacillin effectively treats staphylococcal central nervous system (CNS) infections, particularly meningitis and abscesses. Higher doses (12g/day) significantly improve cure rates compared to lower doses (≤6g/day) in CNS staphylococcal infections.
Area of Science:
- Infectious Diseases
- Neurology
- Pharmacology
Background:
- Staphylococcal infections pose a significant threat to the central nervous system (CNS).
- Effective antibiotic treatment is crucial for managing CNS staphylococcal infections, including meningitis, shunt infections, and brain abscesses.
Purpose of the Study:
- To evaluate the efficacy of cloxacillin in treating staphylococcal CNS infections.
- To determine the optimal dosage of cloxacillin for achieving successful outcomes in these infections.
Main Methods:
- A retrospective review of 20 patients with staphylococcal CNS infections treated with cloxacillin.
- Analysis of treatment outcomes based on cloxacillin dosage and infection type (meningitis, shunt infection, brain abscess).
Main Results:
- Cloxacillin achieved a cure in 15 out of 20 patients.
- Therapeutic failure was associated with cloxacillin doses of 6 g/day or less.
- Successful outcomes were observed with cloxacillin doses of 12 g/day or more.
Conclusions:
- Cloxacillin is an effective antibiotic for treating staphylococcal CNS infections.
- High parenteral doses of cloxacillin (≥12 g/day) are recommended for optimal efficacy.